BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation® (NYSE: TGX), a medical device company serving the cancer treatment and surgical markets, today said that it intends to conduct meetings with certain analysts and institutional investors over the next two weeks.
